Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 11 to 20 of 5992 Results
October 27, 2026
US WorldMeds Acquires Orbus Therapeutics, Expanding Commitment to Rare Diseases and Advancing Eflornithine in Adult Malignant Glioma
Undisclosed
October 27, 2026
Motive Partners Announces the Acquisition of Mobius
Undisclosed
October 27, 2026
Kansai to acquire additional shares of Polisan Kansai Boya Sanayi ve Ticaret A.S. and make it a consolidated subsidiary
$93 Million
October 26, 2026
Meta prices $37.5 billion concurrent offerings of Class A common stock and mandatory convertible preferred stock to support continued investment in AI infrastructure
$37.5 Billion
October 23, 2026
Conduent Completes Asset Sales, Refinancing & Capital Raise in Drop Down Structure
$447 Million
October 22, 2026
Gilead to Acquire Investigational Oral IL-23R Inhibitor HCXT-2001 from PepStar Therapeutics
$1.2 Billion
October 21, 2026
Trane Technologies to Acquire Cancoil
Undisclosed
October 20, 2026
iFood signs agreement to acquire Caju and accelerate the transformation of the corporate benefits market
Undisclosed
October 16, 2026
Charterhouse Capital Partners announces acquisition of Batibig
Undisclosed
October 15, 2026